Kintara Therapeutics Reminds Stockholders to Vote by Thursday to Allow for Completion of the Proposed Merger with TuHURA Biosciences
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 18 2024
0mins
Source: Newsfilter
Voting Deadline for Stockholders: Kintara Therapeutics is urging stockholders to vote by 11:59 p.m. ET on September 19, 2024, to approve Proposals 3 & 5 necessary for the merger with TuHURA Biosciences, as a majority vote is required for completion.
Importance of the Merger: The merger aims to combine oncology assets and technologies to enhance cancer treatment capabilities, with Kintara's CEO emphasizing that failure to complete the merger could jeopardize the company's future.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
